BRIEF-Biopharmx Health Canada approves study of violet iodine

Mon Apr 4, 2016 8:40am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

April 4 (Reuters) - Biopharmx Corp :

* Biopharmx Health Canada approves study of violet iodine

* Results from this study are expected by end of 2016 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)